RSS-Feed abonnieren
DOI: 10.1055/a-1322-5355
Prävalenz von SARS-CoV-2 bei Mitarbeitern eines Krankenhauses der Regel-/Schwerpunktversorgung in Nordrhein-Westfalen
Prevalence of SARS-CoV-2 in employees of a general hospital in Northrhine-Westphalia, GermanyZusammenfassung
Hintergrund Wir erhoben die Prävalenz von SARS-CoV-2 in der Belegschaft eines Krankenhauses der Regel-/Schwerpunktversorgung in Nordrhein-Westfalen im Rahmen einer Querschnittsstudie.
Methode Allen 1363 Mitarbeiter wurden ein nasopharyngealer Abstrich sowie eine Serologie auf SARS-CoV-2 angeboten. Zudem wurde ein Fragebogen zu Vorerkrankungen, Kontakten zu SARS-CoV-2-positiven Personen und COVID-19-typischen Symptomen vorgelegt.
Ergebnisse 1212 MitarbeiterInnen nahmen teil. 19 von 1363 (1,4 %) Mitarbeitern waren PCR-positiv (3 während der Studie, 16 vorher). Bei 40 (3,3 %) bzw. 105 (8,6 %) Mitarbeitern wurde IgG bzw. IgA nachgewiesen, bei 32 (2,6 %) IgG und IgA. Damit wurden insgesamt 47 Mitarbeiter positiv für SARS-CoV-2 getestet. In dieser Gruppe waren die häufigsten Symptome Kopfschmerzen (56 %), Müdigkeit (49 %), Halsschmerzen (49 %) und Husten (46 %), Fieber wurde in 33 % berichtet. Positiv getestete Mitarbeiter gaben häufiger Kontakt zu einem COVID-19-Fall an (60,5 % vs. 37,3 %; p = 0,006). Mitarbeiter mit isoliertem IgA-Nachweis gaben seltener Symptome an.
Schlussfolgerung 3,9 % der Mitarbeiter eines Krankenhauses der Regel-/Schwerpunktversorgung wurden zwischen dem 27.04. und 20.05.2020 positiv auf SARS-CoV-2 getestet. Der Anteil war geringer als erwartet; mögliche Gründe sind die geringe Durchseuchung der Bevölkerung und die umfangreichen, einheitlichen hausinternen Präventionsmaßnahmen.
Abstract
Background We assessed the prevalence of SARS-CoV-2 in the staff of a general hospital in North-Rhine-Westphalia in a cross-sectional study.
Method Employees (n = 1363) were offered a nasopharyngeal swab and serology for SARS-CoV-2. Additionally, employees completed a questionnaire about preexisting conditions, contacts with SARS-CoV-2-positive individuals and COVID-19-specific symptoms.
Results 1212 employees participated. 19 of 1363 (1.4 %) employees tested positive by PCR (3 within and 16 before the study). 40 (3.3 %) and 105 (8.6 %) had IgG and IgA, respectively, 32 (2.6 %) both IgG and IgA. Overall, 47 employees tested positive. In this group, most frequently reported symptoms were headache (56 %), fatigue (49 %), sore throat (49 %), and cough (46 %); fever was reported by 33 %. SARS-CoV-2-positive employees reported more frequently contact with COVID-19 cases (60.5 % vs. 37.3 %, p = 0.006). Employees testing positive only for IgA reported less symptoms.
Conclusion Between 27.04. and 20.05.2020, 3.9 % of the employees working in a general hospital were tested positive for SARS-CoV-2. This proportion was lower than expected; possible explanations are the low level of endemic infection and the extensive, uniform in-house preventative measures.
Schlüsselwörter
Coronavirus - Pandemie - Querschnittsuntersuchung - Prävalenzstudie - ArbeitsmedizinKey words
Coronavirus - pandemic - cross-section analysis - prevalence analysis - occupational medicinePublikationsverlauf
Artikel online veröffentlicht:
29. Januar 2021
© 2021. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
Literatur
- 1 Robert-Koch-Institut. COVID-19: Fallzahlen in Deutschland und weltweit. In 2020 https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Fallzahlen.html
- 2 Karagiannidis C, Mostert C, Hentschker C. et al. Case characteristics, resource use, and outcomes of 10021 patients with COVID-19 admitted to 920 German hospitals: an observational study. Lancet Respir Med 2020; 8: 853-862
- 3 Beigel JH, Tomashek KM, Dodd LE. et al. Remdesivir for the Treatment of Covid-19 – Preliminary Report. N Engl J Med 2020; DOI: 10.1056/NEJMoa2007764.
- 4 Nishiura H, Kobayashi T, Suzuki A. et al. Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19). Int J Infect Dis 2020; DOI: 10.1016/j.ijid.2020.03.020.
- 5 Koh D. Occupational risks for COVID-19 infection. Occup Med (Lond) 2020; 70: 3-5
- 6 Corman VM, Landt O, Kaiser M. et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill 2020; 25 (03) 2000045
- 7 Euroimmun. Characteristics of EUROIMMUN ELISA for COVID-19 diagnostics. In 2020
- 8 Van Elslande J, Houben E, Depypere M. et al. Diagnostic performance of seven rapid IgG/IgM antibody tests and the Euroimmun IgA/IgG ELISA in COVID-19 patients. Clin Microbiol Infect 2020; 26: 1082-1087
- 9 Reusken CB, Buiting A, Bleeker-Rovers C. et al. Rapid assessment of regional SARS-CoV-2 community transmission through a convenience sample of healthcare workers, the Netherlands, March 2020. Euro Surveill 2020; 25 (12) 2000334
- 10 Schwierzeck V, Correa-Martinez CL, Schneider KN. et al. SARS-CoV-2 in the Employees of a Large University Hospital. Dtsch Arztebl Int 2020; 117: 344-345
- 11 Folgueira MD, Munoz-Ruiperez C, Alonso-Lopez MA. et al. SARS-CoV-2 infection in Health Care Workers in a large public hospital in Madrid, Spain, during March 2020. medRxiv 2020; DOI: 10.1101/2020.04.07.20055723:2020.2004.2007.20055723.
- 12 Garcia-Basteiro AL, Moncunill G, Tortajada M. et al. Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a large Spanish reference hospital. Nat Commun 2020; 11: 3500
- 13 Robert-Koch-Institut. Nowcasting und R-Schätzung: Schätzung der aktuellen Entwicklung der SARS-CoV-2-Epidemie in Deutschland. In 2020 https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Projekte_RKI/Nowcasting.html
- 14 Sobral MFF, Duarte GB, da Penha Sobral AIG. et al. Association between climate variables and global transmission oF SARS-CoV-2. Sci Total Environ 2020; 729: 138997
- 15 Liu J, Zhou J, Yao J. et al. Impact of meteorological factors on the COVID-19 transmission: A multi-city study in China. Sci Total Environ 2020; 726: 138513
- 16 Fuhrmann C. The Effects of Weather and Climate on the Seasonality of Influenza: What We Know and What We Need to Know. Geography Compass 2010; 4: 718-730
- 17 Wang X, Tan L, Wang X. et al. Comparison of nasopharyngeal and oropharyngeal swabs for SARS-CoV-2 detection in 353 patients received tests with both specimens simultaneously. Int J Infect Dis 2020; 94: 107-109
- 18 Huang Y, Chen S, Yang Z. et al. SARS-CoV-2 Viral Load in Clinical Samples of Critically Ill Patients. Am J Respir Crit Care Med 2020; DOI: 10.1164/rccm.202003-0572LE.
- 19 To KK, Tsang OT, Leung WS. et al. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. Lancet Infect Dis 2020; 20: 565-574
- 20 Zou L, Ruan F, Huang M. et al. SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients. N Engl J Med 2020; 382: 1177-1179
- 21 Korth J, Wilde B, Dolff S. et al. SARS-CoV-2-specific antibody detection in healthcare workers in Germany with direct contact to COVID-19 patients. J Clin Virol 2020; 128: 104437
- 22 Zhao J, Yuan Q, Wang H. et al. Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019. Clin Infect Dis 2020; DOI: 10.1093/cid/ciaa344.
- 23 Jin Y, Wang M, Zuo Z. et al. Diagnostic value and dynamic variance of serum antibody in coronavirus disease 2019. Int J Infect Dis 2020; 94: 49-52
- 24 Euroimmun. Anti-SARS-CoV-2 ELISA (IgA). In 2020 https://www.coronavirus-diagnostik.de/documents/Indications/Infections/Coronavirus/EI_2606_D_DE_B.pdf
- 25 Meyer B, Drosten C, Muller MA. Serological assays for emerging coronaviruses: challenges and pitfalls. Virus Res 2014; 194: 175-183
- 26 Yongchen Z, Shen H, Wang X. et al. Different longitudinal patterns of nucleic acid and serology testing results based on disease severity of COVID-19 patients. Emerg Microbes Infect 2020; 9: 833-836
- 27 Ju B, Zhang Q, Ge J. et al. Human neutralizing antibodies elicited by SARS-CoV-2 infection. Nature 2020; DOI: 10.1038/s41586-020-2380-z.
- 28 Robert-Koch-Institut. SARS-CoV-2 Steckbrief zur Coronavirus-Krankheit-2019 (COVID-19). In 2020 https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Steckbrief.html;jsessionid=A9C2852F363A25816D60222D96FA660C.internet121?nn=2386228
- 29 Leung NHL, Chu DKW, Shiu EYC. et al. Respiratory virus shedding in exhaled breath and efficacy of face masks. Nat Med 2020; 26: 676-680
- 30 Cheng KK, Lam TH, Leung CC. Wearing face masks in the community during the COVID-19 pandemic: altruism and solidarity. Lancet 2020; DOI: 10.1016/S0140-6736(20)30918-1.